Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MannKind Corp MNKD

Healthcare Biotechnology
MannKind Corporation is a biopharmaceutical company. It is focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. Its technologies include Technosphere dry-powder formulations and Dreamboat inhalation devices, which offers delivery of medicines to the deep lung where they can exert an effect locally or enter the... see more

Recent & Breaking News (NDAQ:MNKD)

BBRY, MNKD, IRBT and SRPT added to NASDAQ Active Stock Watch List at GSR

Accesswire July 25, 2013

TSLA, MNKD, HOLX and ACTG added to NASDAQ Active Stock Watch List at GSR

Accesswire July 22, 2013

MNKD, MU, ALXN and GMCR added to NASDAQ Active Stock Watch List at EPR

Accesswire July 16, 2013

Positive Data, Financial Strategies, Marketing Authorizations, and Collaborations Promote Growth in Biotech Companies - Research Report on Biogen Idec, MannKind, Aegerion, Ariad, and Seattle Genetics

PR Newswire July 10, 2013

MannKind Corporation to Present at 8th Annual JMP Securities Healthcare Conference

Business Wire July 3, 2013

EquityProfileReport.com Initiates Watch List on: ONXX, MNKD, AGNC, and BAC

Marketwired July 2, 2013

Deerfield Invests $160 Million in MannKind Corporation

Business Wire July 1, 2013

MannKind Announces $160 Million Debt Financing

Business Wire July 1, 2013

Pre-Market Review: MannKind, Ariad Pharma, Galena Biopharma, and Novavax

PR Newswire June 28, 2013

Gaining Momentum from Regulatory Wins, Improved Product Labeling, and Leadership Changes - Research Report on Bristol-Myers Squibb, Celgene, Aetna, Theravance, and MannKind

PR Newswire June 26, 2013

TSLA, MNKD, AGNC and ARNA added to Nasdaq Active Stock Watch List at EPR

Accesswire June 24, 2013

Wall Street Fundamentals Releases New In-Depth Stock Reports on CLSN, MNKD, NKTR and VPHM

Accesswire June 24, 2013

RDInvesting Provides Investors with Free In-Depth Equity Reports on BEAT, MNKD, NOK and XRX

Accesswire June 19, 2013

Secrets to Making Money in MNKD, FB, INTC and NWSA

Marketwired June 19, 2013

Advanced Treatment Methods, Significant Study Results, Conferences, and Final Study Data Releases - Research Report on Amgen, Celgene, Vertex Pharmaceuticals, MannKind, and Peregrine Pharmaceuticals

PR Newswire June 18, 2013

MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 2 Diabetes

Business Wire June 17, 2013

Strategy Behind Our Success, We Get in Early: MNKD, ELN, SAN and CHK

Marketwired June 12, 2013

MannKind to Present at Wells Fargo Securities Research & Economics 2013 Healthcare Conference

Business Wire June 11, 2013

Secrets to Making Money in MNKD, ACI, CRM and AMAT

Marketwired June 11, 2013

Positive Findings, Collaborations, and NDA Filings Strengthen Pipelines - Research Report on Clovis Oncology, MannKind, TESARO, Peregrine Pharmaceuticals, and Vanda Pharmaceuticals

PR Newswire June 6, 2013